BNF:

A5.5.3

Status:

Grey - after consultant/specialist recommendation

Decision Date:

November 2014

Comments

GREY after consultant/specialist recommendation:

NICE MTG17: for use in acute or chronic wounds: Second line product after specialist recommendation from Tissue Viability Nurses for chronic sloughy wounds and hyperkeratotic skin around acute or chronic wounds.  (Decision date - November 2014). 

A maximum of 5 dressing (1 box) should be prescribed on the advice of the TVN and if further dressings are required, this needs a review by the TVN. (Decision date - December 2019)  

All other debridement products are classified as DO NOT PRESCRIBE (DNP).

Grey Drug Classifications

• 1: Lack of data on effectiveness compared with standard therapy
• 4: Lack of data on cost-effectiveness compared with standard therapy
• 6: NICE guidance

search again